Guidelines

Heart Disease Care in an Aging Population

The American Heart Association released a 31-page scientific statement offering expert insight into heart disease treatment for an aging US population. 

Considering Age-Related Changes – Cardiovascular changes that occur with normal aging make diagnosing and treating heart disease more complex: large arteries become stiffer, the heart muscle pumps less effectively, and blood vessels are less flexible and less able to respond to changes in the heart’s oxygen needs.

Here are some considerations AHA highlights: 

  • ACS is more likely to occur without chest pain in older adults, presenting with symptoms such as shortness of breath, fainting, or sudden confusion.
  • Measuring levels of circulating troponin is standard to diagnose heart attacks in younger people, but troponin levels may already be higher in older people. Evaluating the rise and fall patterns of troponin may be more appropriate. 
  • Although many clinicians avoid cardiac rehab for frail patients, these are the patients who often benefit the most.
  • Older adults are vulnerable to complications when transferred to outpatient centers; ensuring medications and other therapies are continued among these patients is particularly important. 

Quality of Life Emphasis – The authors note that the goals of care for older people with ACS should extend beyond clinical outcomes like bleeding, stroke, or another heart attack. Goals focused on quality of life may be more important to the patient, placing emphasis on concrete metrics such as pain relief and days spent at home.

The Takeaway

With the US facing an aging population, the AHA’s latest scientific statement provides timely information on the diagnosis and management of ACS in adults over 75. The organization emphasizes clinical considerations for age-related changes and the importance of prioritizing quality of life.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Electrophysiology August 21, 2025

Conduction-System Pacing Succeeds at Treating AV Block August 21, 2025

Conduction-system pacing could be poised to reshape standard care for atrioventricular (AV) block patients after the randomized CSPACE trial demonstrated its significant benefits over traditional right ventricular septal pacing. Taking a closer look at CSP’s potential, the CSPACE trial enrolled 202 patients with AV block at two Australian hospitals, randomizing them to conduction-system pacing or […]

Cardiology Pharmaceuticals August 18, 2025

Rivaroxaban Monotherapy Could Be Better for CAD + AFib August 18, 2025

New analysis from the AFIRE trial suggests rivaroxaban monotherapy might be emerging as a preferred antithrombotic strategy for patients with AFib and stable coronary artery disease, especially in older age groups. The Post Hoc AFIRE Analysis examined 2,215 Japanese patients with AFib and stable CAD, stratifying them into four age groups (<70, 70-74, 75-79, and […]

Surgeries & Interventions August 14, 2025

TEER Could Save Lives in AFMR Patients August 14, 2025

Shedding light on a new treatment for an understudied condition, data published in EHJ suggests that transcatheter edge-to-edge repair (TEER) delivers significant survival advantages in patients with atrial functional mitral regurgitation (FMR). The new OCEAN-Mitral/REVEAL-AFMR Analysis compared 441 TEER-treated patients against 640 medically managed controls with moderate or severe atrial FMR, stating a solid case […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!